Evidence map›Paper›PMID 40518467›Full record

ReviewJournal of the Egyptian National Cancer Institute2025

Successful resection of a huge hepatocellular carcinoma during pregnancy: case report and review of the literature.

Qihui Hu, Jiaxing Li, Jixing Wang, Cong Chen, Rui Tao

Abstract readCase ReportsReview
In one paragraph

Review in Journal of the Egyptian National Cancer Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qihui Hu *Bishan Hospital of Chongqing, Bishan Hospital of Chongqing Medical University, Chongqing, China.
Jiaxing Li *Bishan Hospital of Chongqing, Bishan Hospital of Chongqing Medical University, Chongqing, China.
Jixing WangBishan Hospital of Chongqing, Bishan Hospital of Chongqing Medical University, Chongqing, China.
Cong ChenBishan Hospital of Chongqing, Bishan Hospital of Chongqing Medical University, Chongqing, China.
Rui TaoBishan Hospital of Chongqing, Bishan Hospital of Chongqing Medical University, Chongqing, China. taorui@vip.126.com.

Funding

Natural Science Foundation of Chongqing No. CSTB2022NSCQ-MSX0148Project of Bishan Science and Technology Bureau, Chongqing No. BSKJ20210022
6 · The paper itself

Abstract

backgroundHepatocellular carcinoma during pregnancy is rare and poses significant potential risks to both the pregnant individual and the fetus. Here, we report a case of hepatocellular carcinoma during pregnancy. The 28-week gestational is a critical point of fetal maturation. A literature review revealed no similar case with survival exceeding 2 years, following resection of a large hepatocellular carcinoma diagnosed in late-stage pregnancy. This article may contribute to future research aimed at extending the survival time of patients with hepatocellular carcinoma diagnosed in late pregnancy. CASE PRESENTATION: A 33-year-old pregnant woman was diagnosed with hepatocellular carcinoma at 34 weeks of pregnancy. A cesarean section was performed at 34 weeks of pregnancy. Under general anesthesia, a right lobectomy of the liver was conducted after 15 days. The patient received continuous support from the clinical psychology team throughout the entire perioperative period. The postoperative recovery was smooth, and the patient was discharged without any significant complications. Approximately 2 years post-surgery, follow-up indicated that the patient remained alive and in good health.

conclusionsThe physiological changes associated with pregnancy can promote rapid tumor growth, leading to poor prognoses. Expert decision-making should be guided by the growth and maturation status of the fetus in relation to hepatocellular carcinoma development. For patients in the late stage of pregnancy, timely termination of pregnancy and tumor resection surgery, along with obtaining assistance from the clinical psychology team during the perioperative period, followed by post-discharge treatment with a combination of Sintilimab and Lenvatinib, constitutes an effective strategy for prolonging patient survival.

Indexed as

Carcinoma, HepatocellularHepatectomyLiver NeoplasmsPregnancy Complications, NeoplasticAdultCesarean SectionFemaleHumansPregnancyTreatment OutcomeCase reportHepatectomyHepatocellular carcinomaPregnancyPsychological support

Identifiers

PMID40518467
PMCPMC13313421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.